Do we need a different staging system for tongue and gingivobuccal complex squamous cell cancers?
- PMID: 29496060
- PMCID: PMC5836801
- DOI: 10.1016/j.oraloncology.2018.01.013
Do we need a different staging system for tongue and gingivobuccal complex squamous cell cancers?
Abstract
Objectives: To determine the need for a separate staging system for gingivobuccal complex squamous cell cancers (GBCSCC) based on 5-year overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) data from one institution.
Patients and methods: An Institutional Review Board (IRB)-approved retrospective analysis was performed on an oral cavity cancer patient database. Patients from 1985 to 2012 with primary surgical treatment for biopsy-proven squamous cell cancer (SCC) from either the oral tongue (TSCC Group) or gingivobuccal complex (GBCSCC Group), were selected as two separate subgroups. The clinicopathologic data were used to stage the patients based on the American Joint Committee on Cancer 7th edition. Survival outcomes including 5-year OS, RFS, and DSS were calculated and analyzed. A multivariate analysis was performed to identify if subsite was an independent predictor for the survival outcomes, adjusting for other variables. A p-value of less than .05 was considered statistically significant.
Results: 936 patients with TSCC and 486 patients with GBCSCC were considered eligible for the analysis. Patients with GBCSCC were more likely to be older (p < .001) and presented with more advanced disease (p < .001) compared to patients with TSCC. Unadjusted hazard ratio (HR) suggested GBCSCC had poor OS compared to TSCC. However, after adjusting for other variables, the adjusted HR was not significant (p = .593). There was no difference in 5-year DSS or RFS in either of the study groups.
Conclusion: With similar survival outcomes by stage, there is no justification for using a different staging system for GBCSCC.
Keywords: AJCC; Gingivobuccal; Head and neck cancer; Oral cancer; Prognosis; Retrospective studies; Squamous cell; Staging; Survival; Tongue.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Conflict of interest statement
None.
Figures
Similar articles
-
Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer.Virchows Arch. 2018 Oct;473(4):481-487. doi: 10.1007/s00428-018-2417-y. Epub 2018 Jul 23. Virchows Arch. 2018. PMID: 30039390
-
Prognostic performance of the American Joint Committee on Cancer 8th edition of the TNM staging system in patients with early oral tongue cancer.Head Neck. 2019 May;41(5):1270-1276. doi: 10.1002/hed.25553. Epub 2018 Dec 10. Head Neck. 2019. PMID: 30537405
-
Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.Cancer. 2008 Jan 15;112(2):345-51. doi: 10.1002/cncr.23183. Cancer. 2008. PMID: 18041071
-
Elective Neck Dissection vs Observation in Early-Stage Squamous Cell Carcinoma of the Oral Tongue With No Clinically Apparent Lymph Node Metastasis in the Neck: A Systematic Review and Meta-analysis.JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):857-65. doi: 10.1001/jamaoto.2016.1281. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 27442962 Review.
-
MicroRNAs in human tongue squamous cell carcinoma: From pathogenesis to therapeutic implications.Oral Oncol. 2017 Apr;67:124-130. doi: 10.1016/j.oraloncology.2017.02.015. Epub 2017 Feb 27. Oral Oncol. 2017. PMID: 28351566 Review.
Cited by
-
Invasion of the bucco-mandibular space by oral squamous cell carcinoma: histopathological analysis of invasion pattern.Front Oncol. 2023 Oct 12;13:1168376. doi: 10.3389/fonc.2023.1168376. eCollection 2023. Front Oncol. 2023. PMID: 37901328 Free PMC article.
-
Clinicopathological Difference Between Gingivobuccal and Oral Tongue Cancers: A Cross-Sectional Observational Study from a Tertiary Healthcare Centre in Northern India.Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):6262-6267. doi: 10.1007/s12070-021-03025-6. Epub 2022 Jan 6. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 36742819 Free PMC article.
-
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques.Front Oncol. 2021 Mar 12;11:619372. doi: 10.3389/fonc.2021.619372. eCollection 2021. Front Oncol. 2021. PMID: 33777764 Free PMC article.
-
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer.Clin Cancer Res. 2020 Jul 1;26(13):3110-3116. doi: 10.1158/1078-0432.CCR-19-3484. Epub 2020 Apr 3. Clin Cancer Res. 2020. PMID: 32245901 Free PMC article. Clinical Trial.
-
Survival outcomes after treatment of cancer of the oral cavity (1985-2015).Oral Oncol. 2019 Mar;90:115-121. doi: 10.1016/j.oraloncology.2019.02.001. Epub 2019 Feb 15. Oral Oncol. 2019. PMID: 30846169 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. - PubMed
-
- Sarode SC, Sarode GS, Karmarkar S, Tupkari JV. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol. 2011;47(9):920–1. - PubMed
-
- Nair S, Singh B, Pawar PV, Datta S, Nair D, Kane S, et al. Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically different entities. Eur Arch Otorhinolaryngol. 2016;273:3921–8. - PubMed
-
- Pathak KA, Gupta S, Talole S, Khanna V, Chaturvedi P, Deshpande MS, et al. Advanced squamous cell carcinoma of lower gingivobuccal complex: Patterns of spread and failure. Head Neck. 2005;27(7):597–602. - PubMed
-
- Niu LX, Feng ZE, Wang DC, Zhang JY, Sun ZP, Guo CB. Prognostic factors in mandibular gingival squamous cell carcinoma: A 10-year retrospective study. Int J Oral Maxillofacial Surg. 2017;46:137–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
